hotspot -WSS

hotspot

author：leisure time 2025-10-01 18:32:43 - browse：94981

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And will there ever be an Apple of pharma?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. In the wake of a massively important clinical trial of Novo Nordisk’s obesity drug Wegovy, our colleague Elaine Chen joins us to explain what we know and don’t know about data that could change the practice of medicine. Then, Mizuho Securities biotech strategist Jared Holz calls in to discuss whether explosive popularity of obesity treatments could help create the first trillion-dollar drug company.

For more on what we cover, here’s the news on the Wegovy study; here’s more on its implications; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medical records are filled with copy
Next article： Eye stem cell transplant could help restore vision in injured people

WSS

Baltimore teen accused of firing into crowd during block party mass shooting

Hilary expected to bring catastrophic, life

The pain doctors face in trying to build their families

Patient advocates sound warning on FDA proposal on salt intake

Hilary may become 1st tropical storm to make landfall in California in 84 years

Health and fitness trackers are measuring the wrong things

hotspot

hotspot

focus

Medicare proposal to cover medical devices draws a mixed reaction

Ukraine taking heavy casualties 10 weeks into its counteroffensive

United colonoscopy coverage change 'may cost lives,' doctors say

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Novavax promises a turnaround & Lilly roils the obesity market

FDA approves first treatment for ultra

DIEP, the 'gold standard' of breast reconstruction, is under threat

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Tori Bowie and the unacceptable rates of Black maternal death

Heart disease and mental health: A look at cardiac psychology

knowledge

Health and fitness trackers are measuring the wrong things

Trump's false claims about Georgia's 2020 election long debunked

Lung cancer is America's deadliest cancer. Yet so few get screened

Cancer drug shortages' outsize impact on ovarian cancer patients

Idaho abortion case may prompt more restrictions in other states

Listen: Racing for gene therapy & a pioneering approval

leisure time

focus

leisure time

focus